New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling

How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling

by Jeff Hansen,University of Alabama at BirminghamKnowledge of this previously unrecognized mechanism may aid therapy for patients with interleukin-6 signaling mutations and hyper-IgE Syndrome,
inflammatory disease January 29,2024
How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling

How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling

by Jeff Hansen,University of Alabama at BirminghamKnowledge of this previously unrecognized mechanism may aid therapy for patients with interleukin-6 signaling mutations and hyper-IgE Syndrome,
inflammatory disease January 29,2024
Tool predicts a patient's risk of developing psoriatic arthritis

Tool predicts a patient's risk of developing psoriatic arthritis

by WileyCredit: Unsplash/CC0 Public DomainIn research published inArthritis & Rheumatology, investigators have developed and validated a tool called PRESTO that identifies patients with
Arthritis and Rheumatism January 29,2024
Tool predicts a patient's risk of developing psoriatic arthritis

Tool predicts a patient's risk of developing psoriatic arthritis

by WileyCredit: Unsplash/CC0 Public DomainIn research published inArthritis & Rheumatology, investigators have developed and validated a tool called PRESTO that identifies patients with
Arthritis and Rheumatism January 29,2024
Long COVID not caused by COVID-19 immune inflammatory response, new research finds

Long COVID not caused by COVID-19 immune inflammatory response, new research finds

by University of BristolOngoing symptoms at three months and associations with immune profiles. (A,B) The percentage of patients with mild (N=17), moderate (N=32), and severe (N=14) coronav
inflammatory disease January 29,2024
Long COVID not caused by COVID-19 immune inflammatory response, new research finds

Long COVID not caused by COVID-19 immune inflammatory response, new research finds

by University of BristolOngoing symptoms at three months and associations with immune profiles. (A,B) The percentage of patients with mild (N=17), moderate (N=32), and severe (N=14) coronav
inflammatory disease January 29,2024
Non-antibiotic treatment for women with persistent acne shown to be effective

Non-antibiotic treatment for women with persistent acne shown to be effective

byUniversity of SouthamptonMean Acne-QoL symptom subscale score by time point for each treatment group. QoL=quality of life. Credit:BMJ(2023). DOI: 10.1136/bmj-2022-074349A team of r
inflammatory disease January 29,2024
Non-antibiotic treatment for women with persistent acne shown to be effective

Non-antibiotic treatment for women with persistent acne shown to be effective

byUniversity of SouthamptonMean Acne-QoL symptom subscale score by time point for each treatment group. QoL=quality of life. Credit:BMJ(2023). DOI: 10.1136/bmj-2022-074349A team of r
inflammatory disease January 29,2024
Stress rash: What is it and how to treat it

Stress rash: What is it and how to treat it

by Sue Benzuly, RNWe know that stress can take a toll on the body, but many may not realize it can produce a rash."Stress can increase the level of the hormone cortisol, increasing inflammation i
Dermatology January 29,2024
Stress rash: What is it and how to treat it

Stress rash: What is it and how to treat it

by Sue Benzuly, RNWe know that stress can take a toll on the body, but many may not realize it can produce a rash."Stress can increase the level of the hormone cortisol, increasing inflammation i
Dermatology January 29,2024
The future of IgE-mediated allergy research and treatments

The future of IgE-mediated allergy research and treatments

by Melissa Rohman,Northwestern UniversityType 2 cell subsets play diverse roles in the pathogenesis of food allergy. Tfh13 and peTh2 cells have been identified in food allergy. Tfh13 cells are l
inflammatory disease January 29,2024
The future of IgE-mediated allergy research and treatments

The future of IgE-mediated allergy research and treatments

by Melissa Rohman,Northwestern UniversityType 2 cell subsets play diverse roles in the pathogenesis of food allergy. Tfh13 and peTh2 cells have been identified in food allergy. Tfh13 cells are l
inflammatory disease January 29,2024
Atopic dermatitis tied to higher venous thromboembolism risk

Atopic dermatitis tied to higher venous thromboembolism risk

by Lori SolomonAtopic dermatitis (AD) in adulthood is associated with an increased risk for venous thromboembolism (VTE), according to a study published online May 31 inJAMA Dermatology.Tai-Li C
inflammatory disease January 29,2024
Atopic dermatitis tied to higher venous thromboembolism risk

Atopic dermatitis tied to higher venous thromboembolism risk

by Lori SolomonAtopic dermatitis (AD) in adulthood is associated with an increased risk for venous thromboembolism (VTE), according to a study published online May 31 inJAMA Dermatology.Tai-Li C
inflammatory disease January 29,2024
Mindfulness, self-compassion training improves quality of life for eczema patients

Mindfulness, self-compassion training improves quality of life for eczema patients

by Elana GotkineA mindfulness and self-compassion training intervention is effective for improving quality of life (QOL) among adults with atopic dermatitis, according to a study published online May
inflammatory disease January 29,2024
Mindfulness, self-compassion training improves quality of life for eczema patients

Mindfulness, self-compassion training improves quality of life for eczema patients

by Elana GotkineA mindfulness and self-compassion training intervention is effective for improving quality of life (QOL) among adults with atopic dermatitis, according to a study published online May
inflammatory disease January 29,2024
How cadmium-induced inflammation increases the severity and mortality of lung infections

How cadmium-induced inflammation increases the severity and mortality of lung infections

by Jeff Hansen,University of Alabama at BirminghamCredit: Unsplash/CC0 Public DomainA key mechanism of cadmium-linked inflammation that increases severity and mortality of lung infections has be
inflammatory disease January 29,2024
How cadmium-induced inflammation increases the severity and mortality of lung infections

How cadmium-induced inflammation increases the severity and mortality of lung infections

by Jeff Hansen,University of Alabama at BirminghamCredit: Unsplash/CC0 Public DomainA key mechanism of cadmium-linked inflammation that increases severity and mortality of lung infections has be
inflammatory disease January 29,2024
NLRP12 as a new drug target for infection, inflammation and hemolytic diseases

NLRP12 as a new drug target for infection, inflammation and hemolytic diseases

by St. Jude Children's Research HospitalGraphical Abstract. Credit:Cell(2023). DOI: 10.1016/j.cell.2023.05.005Infections and other diseases can cause red blood cells to rupture, r
inflammatory disease January 29,2024
NLRP12 as a new drug target for infection, inflammation and hemolytic diseases

NLRP12 as a new drug target for infection, inflammation and hemolytic diseases

by St. Jude Children's Research HospitalGraphical Abstract. Credit:Cell(2023). DOI: 10.1016/j.cell.2023.05.005Infections and other diseases can cause red blood cells to rupture, r
inflammatory disease January 29,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com